Expression of CLU in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

CLU is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 22529.1

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

20296.0

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	109598.0
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	83337.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	48721.6
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	46144.1
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	40870.7
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	40557.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	39509.3
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	36557.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	36280.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	36016.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	35602.4
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	35054.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	34542.4
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	34530.1
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	34439.8
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	34201.9
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	34069.2
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	34010.2
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	33182.1
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	32777.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	32348.7
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	32071.4
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	31948.9
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	31767.9
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	30859.2
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	30038.1
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	29558.1
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	29276.7
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	28363.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	28239.3
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	27632.8
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	27564.3
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	27452.3
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	27217.2
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	26702.8
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	26683.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	26311.8
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	25707.9
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	25111.8
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	24524.9
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	24201.2
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	23897.3
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	23594.3
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	23580.4
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	23509.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	23497.1
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	23409.7
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	23135.3
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	21923.0
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	21902.8
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	21891.6
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	21880.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	21833.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	21460.0
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	21415.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	21284.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	21132.1
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	21092.3
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	20586.1
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	20480.5
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	20364.7
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	19521.2
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	19415.8
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	19209.0
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	18911.0
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	18855.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	18814.7
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	18630.1
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	18372.0
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	18252.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	18134.8
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	17873.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	17437.0
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	17344.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	17316.4
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	16955.6
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	16913.1
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	16753.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	16234.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	16112.1
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	16059.2
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	15808.2
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	15542.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	15198.7
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	15135.0
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	14926.9
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	14884.9
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	14804.7
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	14657.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	14358.4
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	14167.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	13797.1
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	13672.0
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	13298.3
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	13203.8
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	13200.0
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	12910.3
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	12766.8
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	12387.0
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	12327.6
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	12313.6
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	12090.1
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	11981.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	11858.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	11845.0
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	11722.4
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	11650.8
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	11639.5
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	11619.2
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	11412.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	11078.0
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	10929.1
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	10881.2
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	10620.2
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	10560.6
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	10506.3
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	10458.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	9917.7
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	9568.1
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	9305.8
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	8835.1
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	8636.4
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	8455.9
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	8335.2
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	8281.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	7970.8
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	7364.1
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	7340.2
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	6589.2
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	6551.4
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	6450.0
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	6328.2
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	5291.6
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	4928.1
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	4733.4
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	4279.4
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2628.9
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2417.4
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2139.8
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1977.3
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	621.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

CLU is potential prognostic, high expression is unfavorable in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1531.66

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2623.3

Number of samples

Samples

Sample	Description	pTPM
AK183	N, NA, stage:NA, alive, 360 days	7471.9
AK005	N, NA, stage:NA, dead, 240 days	6787.4
AK068	N, NA, stage:NA, alive, 360 days	6587.0
AK055	N, NA, stage:NA, dead, 240 days	6408.0
AK091	N, NA, stage:NA, dead, 210 days	6005.6
AK153	N, NA, stage:NA, dead, 240 days	5536.9
AK076	N, NA, stage:NA, alive, 660 days	5416.9
AK117	N, NA, stage:NA, dead, 210 days	5287.6
AK006	N, NA, stage:NA, dead, 360 days	4619.6
AK071	N, NA, stage:NA, dead, 540 days	4584.5
AK167	N, NA, stage:NA, dead, 180 days	4415.6
AK053	N, NA, stage:NA, dead, 300 days	3449.9
AK158	N, NA, stage:NA, dead, 360 days	3368.5
AK178	N, NA, stage:NA, dead, 240 days	3313.3
AK236	N, NA, stage:NA, dead, 360 days	3112.9
AK072	N, NA, stage:NA, dead, 150 days	3046.6
AK216	N, NA, stage:NA, dead, 360 days	3039.7
AK003	N, NA, stage:NA, dead, 600 days	2967.2
AK015	N, NA, stage:NA, alive, 720 days	2693.7
AK188	N, NA, stage:NA, alive, 420 days	2660.7
AK049	N, NA, stage:NA, dead, 180 days	2659.0
AK227	N, NA, stage:NA, alive, 300 days	2654.5
AK199	N, NA, stage:NA, alive, 1860 days	2653.7
AK079	N, NA, stage:NA, dead, 210 days	2435.5
AK139	N, NA, stage:NA, dead, 270 days	2420.2
AK218	N, NA, stage:NA, dead, 180 days	2350.8
AK123	N, NA, stage:NA, dead, 180 days	2309.3
AK088	N, NA, stage:NA, dead, 360 days	2305.7
AK231	N, NA, stage:NA, dead, 240 days	2284.3
AK051	N, NA, stage:NA, dead, 360 days	2281.7
AK134	N, NA, stage:NA, dead, 360 days	2260.7
AK149	N, NA, stage:NA, dead, 420 days	2239.0
AK030	N, NA, stage:NA, dead, 120 days	2184.8
AK089	N, NA, stage:NA, dead, 330 days	2067.9
AK099	N, NA, stage:NA, dead, 420 days	2047.3
AK195	N, NA, stage:NA, dead, 390 days	1745.2
AK226	N, NA, stage:NA, dead, 360 days	1646.4
AK081	N, NA, stage:NA, dead, 180 days	1565.8
AK035	N, NA, stage:NA, dead, 210 days	1557.6
AK165	N, NA, stage:NA, alive, 360 days	1505.7
AK098	N, NA, stage:NA, dead, 660 days	1373.7
AK100	N, NA, stage:NA, alive, 960 days	1372.4
AK173	N, NA, stage:NA, dead, 180 days	1324.8
AK102	N, NA, stage:NA, alive, 1740 days	1320.1
AK133	N, NA, stage:NA, dead, 360 days	1287.4
AK205	N, NA, stage:NA, dead, 120 days	1267.8
AK213	N, NA, stage:NA, alive, 2010 days	1253.9
AK142	N, NA, stage:NA, alive, 90 days	1084.3
AK041	N, NA, stage:NA, alive, 810 days	1076.6
AK103	N, NA, stage:NA, alive, 1320 days	1048.3
AK124	N, NA, stage:NA, alive, 1920 days	1017.7
AK074	N, NA, stage:NA, alive, 300 days	900.2
AK085	N, NA, stage:NA, alive, 660 days	867.4
AK185	N, NA, stage:NA, alive, 330 days	839.5
AK156	N, NA, stage:NA, dead, 330 days	768.7
AK066	N, NA, stage:NA, alive, 960 days	717.1
AK002	N, NA, stage:NA, dead, 570 days	350.0
AK043	N, NA, stage:NA, alive, 660 days	334.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0205570003	Tumor	2.7
CPT0217000004	Tumor	2.6
CPT0093550003	Tumor	1.8
CPT0123530003	Tumor	1.7
CPT0087570003	Tumor	1.4
CPT0087730003	Tumor	1.3
CPT0162100003	Tumor	1.1
CPT0092440003	Tumor	1.1
CPT0079790003	Tumor	1.0
CPT0206450003	Tumor	0.8
CPT0189650004	Tumor	0.8
CPT0168380003	Tumor	0.8
CPT0093360003	Tumor	0.7
CPT0206230003	Tumor	0.7
CPT0162020003	Tumor	0.5
CPT0206110003	Tumor	0.5
CPT0189460003	Tumor	0.4
CPT0186100003	Tumor	0.4
CPT0219080004	Tumor	0.4
CPT0064650003	Tumor	0.4
CPT0002410011	Tumor	0.3
CPT0206880003	Tumor	0.3
CPT0087950003	Tumor	0.3
CPT0190360004	Tumor	0.3
CPT0127480003	Tumor	0.3
CPT0196850003	Tumor	0.2
CPT0168590003	Tumor	0.2
CPT0224540004	Tumor	0.1
CPT0078580003	Tumor	0.1
CPT0093510003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0218690004	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0217880003	Tumor	-0.1
CPT0127420003	Tumor	-0.1
CPT0167640003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0205450004	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0206560003	Tumor	-0.2
CPT0221180003	Tumor	-0.2
CPT0168080003	Tumor	-0.3
CPT0168830003	Tumor	-0.3
CPT0175060003	Tumor	-0.3
CPT0189750004	Tumor	-0.3
CPT0104220003	Tumor	-0.3
CPT0205780003	Tumor	-0.3
CPT0204370003	Normal	-0.3
CPT0168720003	Tumor	-0.3
CPT0182500003	Tumor	-0.3
CPT0167970003	Tumor	-0.3
CPT0206000004	Tumor	-0.3
CPT0125220003	Tumor	-0.4
CPT0225730003	Tumor	-0.4
CPT0209440003	Tumor	-0.5
CPT0071100003	Tumor	-0.5
CPT0201710003	Tumor	-0.5
CPT0167860004	Tumor	-0.5
CPT0217190003	Tumor	-0.5
CPT0224330003	Tumor	-0.5
CPT0204350003	Normal	-0.6
CPT0218670003	Tumor	-0.6
CPT0168270003	Tumor	-0.6
CPT0093590003	Tumor	-0.6
CPT0206670004	Tumor	-0.6
CPT0208980003	Tumor	-0.6
CPT0205670004	Tumor	-0.6
CPT0218770003	Tumor	-0.6
CPT0204330003	Normal	-0.6
CPT0204420003	Normal	-0.6
CPT0204360003	Normal	-0.7
CPT0199770003	Tumor	-0.7
CPT0204380003	Normal	-0.7
CPT0228220003	Tumor	-0.7
CPT0206330003	Tumor	-0.7
CPT0171580008	Tumor	-0.7
CPT0225760003	Tumor	-0.7
CPT0125510003	Tumor	-0.7
CPT0182550003	Tumor	-0.7
CPT0167530003	Tumor	-0.7
CPT0189850004	Tumor	-0.8
CPT0218830004	Tumor	-0.8
CPT0093450003	Tumor	-0.8
CPT0217710008	Tumor	-0.8
CPT0162140003	Tumor	-0.9
CPT0224390004	Tumor	-0.9
CPT0167750004	Tumor	-0.9
CPT0204400003	Normal	-0.9
CPT0104330003	Tumor	-0.9
CPT0189250003	Tumor	-0.9
CPT0190240004	Tumor	-0.9
CPT0204340003	Normal	-1.0
CPT0204390003	Normal	-1.0
CPT0182580003	Tumor	-1.0
CPT0189570004	Tumor	-1.1
CPT0168480003	Tumor	-1.1
CPT0218960004	Tumor	-1.1
CPT0206780003	Tumor	-1.1
CPT0207030003	Tumor	-1.2
CPT0161730003	Tumor	-1.2
CPT0204410003	Normal	-1.2
CPT0218330004	Tumor	-1.2
CPT0207090003	Tumor	-1.3
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA000572	Antibody CAB016253	Antibody CAB080180
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade